Quick Answer ADOBE INC. reported Stockholders Equity of $11.62 billion for fiscal year 2025. ADOBE INC. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $11.62B -17.6% 2024 $14.11B -14.6% 2023 $16.52B +17.6% 2022 $14.05B -5.0% 2021 $14.80B +11.6% 2020 $13.26B +26.0% 2019 $10.53B +12.5% 2018 $9.36B +10.7% 2017 $8.46B +13.9% 2016 … Read more
Quick Answer ADOBE INC. reported Long-Term Debt of $6.21 billion for fiscal year 2025. ADOBE INC. Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $6.21B +50.4% 2024 $4.13B +13.6% 2023 $3.63B +0.1% 2022 $3.63B -12.0% 2021 $4.12B +312.3% 2009 $1.00B +185.7% 2008 $350.00M — Quarterly Long-Term Debt Quarter Ending Long-Term Debt … Read more
Quick Answer ADOBE INC. reported Total Assets of $29.50 billion for fiscal year 2025. ADOBE INC. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $29.50B -2.4% 2024 $30.23B +1.5% 2023 $29.78B +9.6% 2022 $27.16B -0.3% 2021 $27.24B +12.2% 2020 $24.28B +17.0% 2019 $20.76B +10.6% 2018 $18.77B +29.1% 2017 $14.54B +14.5% 2016 … Read more
Quick Answer ADOBE INC. reported Cash and Equivalents of $5.43 billion for fiscal year 2025. ADOBE INC. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $5.43B -28.7% 2024 $7.61B +6.6% 2023 $7.14B +68.6% 2022 $4.24B +10.2% 2021 $3.84B -14.2% 2020 $4.48B +69.0% 2019 $2.65B +61.3% 2018 $1.64B -28.8% 2017 … Read more
Quick Answer ADOBE INC. reported Diluted EPS of $16.70 per share for fiscal year 2025. ADOBE INC. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $16.70 +35.1% 2024 $12.36 +4.6% 2023 $11.82 +17.0% 2022 $10.10 +0.8% 2021 $10.02 -7.5% 2020 $10.83 +80.5% 2019 $6.00 +15.4% 2018 $5.20 +53.8% 2017 $3.38 +45.7% … Read more
Quick Answer ADOBE INC. reported Net Income of $7.13 billion for fiscal year 2025. ADOBE INC. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $7.13B +28.2% 2024 $5.56B +2.4% 2023 $5.43B +14.1% 2022 $4.76B -1.4% 2021 $4.82B -8.3% 2020 $5.26B +78.2% 2019 $2.95B +13.9% 2018 $2.59B +53.0% 2017 $1.69B +44.9% 2016 … Read more
Quick Answer ADOBE INC. reported Total Revenue of $23.77 billion for fiscal year 2025. ADOBE INC. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $23.77B+10.5% $21.50B+10.8% $19.41B+10.2% $17.61B+11.5% $15.79B+22.7% $12.87B+15.2% Net Income $7.13B+28.2% $5.56B+2.4% $5.43B+14.1% $4.76B-1.4% $4.82B-8.3% $5.26B+78.2% Diluted EPS $16.70+35.1% $12.36+4.6% $11.82+17.0% $10.10+0.8% $10.02-7.5% $10.83+80.5% Total Assets $29.50B-2.4% … Read more
Quick Answer ADOBE INC. reported Total Revenue of $23.77 billion for fiscal year 2025. ADOBE INC. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $23.77B +10.5% 2024 $21.50B +10.8% 2023 $19.41B +10.2% 2022 $17.61B +11.5% 2021 $15.79B +22.7% 2020 $12.87B +15.2% 2019 $11.17B +23.7% 2018 $9.03B +23.7% 2017 $7.30B +24.7% 2016 … Read more
Quick Answer Adaptimmune Therapeutics PLC reported Shares Outstanding of 1.54 billion shares for fiscal year 2024. Adaptimmune Therapeutics PLC Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2024 1.54B +12.7% 2023 1.36B +38.1% 2022 987.11M +6.3% 2021 928.55M -0.0% 2020 928.75M +47.2% 2019 631.00M +0.6% 2018 627.45M +11.6% 2017 562.12M +32.3% 2016 … Read more
Quick Answer Adaptimmune Therapeutics PLC reported R&D Expense of $149.06 million for fiscal year 2024. Adaptimmune Therapeutics PLC R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2024 $149.06M +17.8% 2023 $126.51M -1.0% 2022 $127.73M +15.0% 2021 $111.09M +21.3% 2020 $91.57M -6.1% 2019 $97.50M -0.8% 2018 $98.27M +12.5% 2017 $87.39M +37.0% 2016 $63.79M … Read more